文献速递乳腺乳腺X线

乳腺筛查中测试集评估方案遗漏癌症与真实阅片表现的关系

The relationship between missed breast cancers on mammography in a test-set based assessment scheme and real-life performance in a National Breast Screening Programme.
PubMed 文献 · Eur J Radiol · 2021-07-28

本研究回顾性分析英国NHSBSP中536名乳腺X线阅片者,比较其在PERFORMS测试集中遗漏的癌症数量与真实双阅片中第一阅片者遗漏而第二阅片者正确识别的癌症率。结果显示两者呈高度显著正相关(Pearson r=0.228,Spearman rho=0.265,均p<.0001),且年阅片量是否超过1500例对遗漏率无显著影响(p=.0643)。结论认为测试集评估方案能准确反映真实阅片表现,可用于识别表现较差的阅片者。

要点

  • PERFORMS测试集遗漏癌症数与真实阅片遗漏率呈显著正相关,可用于评估阅片者表现。
  • 年首读量≥1500例与<1500例的阅片者间遗漏率无显著差异。
  • 双阅片中第一阅片者遗漏的癌症可作为真实表现指标与测试集结果对比。

核心结论

  • 基于测试集的评估方案(PERFORMS)能准确反映真实乳腺X线阅片表现,可用于识别表现较差的阅片者。

研究设计与样本

  • 回顾性研究,纳入英国NHSBSP中536名同意参与的阅片者,比较其3年内真实双阅片中第一阅片者遗漏但第二阅片者正确识别的癌症率与PERFORMS测试集遗漏癌症数。
  • NHSBSP要求阅片者每年至少首读1500例,据此将阅片者分为超过目标组(452名)与未超过组,比较两组遗漏率。
  • 采用参数与非参数相关性分析(Pearson相关、Spearman's rho)及t检验。

诊断标准与关键数值

  • 真实遗漏癌症指标与PERFORMS测试集遗漏癌症指标呈高度显著正相关:Pearson Correlation=0.228(n=536,p<.0001),Spearman's rho=0.265(n=536,p<.0001)。
  • 年首读量超过1500例的452名阅片者与未超过者之间,遗漏癌症率无显著差异(t(94.2)=-1.87,p=.0643,r=0.19)。

临床应用与阅片要点

  • 可将PERFORMS测试集遗漏癌症数作为真实阅片表现的替代指标,用于筛查项目中的阅片者质量评估。
  • 真实双阅片中第一阅片者遗漏而第二阅片者正确识别的癌症可作为监测个体阅片表现的实用指标。
  • 年阅片量未达1500例首读目标与遗漏率无显著关联,提示阅片量本身可能不是决定表现的关键因素。

局限性

  • 回顾性研究设计。
  • 仅纳入同意参与的阅片者,可能存在选择偏倚。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: This retrospective study determined whether a test-set based assessment scheme (PERFORMS) used in a national breast screening programme could be used to predict real-life performance by investigating if the number of cancers missed by mammography readers in real-life related to the number of cancers missed in the PERFORMS test-set and whether real-life reading volumes affected performance.

METHOD: Data was obtained from consenting readers in the screening programme in England (NHSBSP) where double reading is standard. The rate of cancers missed by individual first readers but correctly identified by second readers was compared with the number of cancers missed in the PERFORMS test-set over a 3-year period. NHSBSP readers are required to interpret at least 1500 cases per year as a first reader, so results were compared between readers who exceeded this target and those that did not. Parametric and non-parametric correlations were calculated.

RESULTS: Amongst the 536 readers, there was a highly significant positive correlation between the real-life and PERFORMS test-set missed cancer metrics (Pearson Correlation = 0.228, n = 536, p < .0001, Spearman's rho = 0.265, n = 536, p < .0001). There was no significant difference in rates of missed cancers between the 452 readers who exceeded the 1500 first read per year target and those who did not (t(94.2) = -1.87, p = .0643, r = 0.19).

CONCLUSIONS: The use of a test-set based assessment scheme accurately reflects real-life mammography reading performance, indicating that it can be a useful tool in identifying poor reader performance.

来源:Eur J Radiol,查看原文。版权归原作者所有。

引用

  1. Chen Y, James JJ, Michalopoulou E, et al. The relationship between missed breast cancers on mammography in a test-set based assessment scheme and real-life performance in a National Breast Screening Programme. Eur J Radiol. 2021. PMID: 34352657. doi:10.1016/j.ejrad.2021.109881

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。